CRSP

40.53

0.57% 0.23

Pre-mercato: 41.20 0.67 +1.65%

Crispr Therapeutics Ag (CRSP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CRSP Giù? Forum Previsione

Precedente Chiudi:

$40.30

Aprire:

$41

Volume 24 ore:

1.35M

Relative Volume:

0.79

Capitalizzazione di mercato:

$3.46B

Reddito:

$170.10M

Utile/perdita netta:

$-239.59M

Rapporto P/E:

-14.48

EPS:

-2.8

Flusso di cassa netto:

$-191.20M

1 W Prestazione:

+2.12%

1M Prestazione:

-9.19%

6M Prestazione:

-32.99%

1 anno Prestazione:

-33.40%

Intervallo 1D:

$40.45

$41.55

Intervallo di 1 settimana:

$36.52

$41.55

Portata 52W:

$36.52

$91.10

Crispr Therapeutics Ag Stock (CRSP) Company Profile

Nome

Crispr Therapeutics Ag

Settore

Healthcare (1172)

Industria

Biotechnology (684)

Telefono

(617) 315-4600

Indirizzo

BAARERSTRASSE 14, ZUG

Dipendente

407

Cinguettio

@crisprtx

Prossima data di guadagno

2024-12-05

Ultimi documenti SEC

CRSP's Discussions on Twitter

Confronta CRSP con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CRSP Crispr Therapeutics Ag	40.53	3.46B	170.10M	-239.59M	-191.20M	-2.80
VRTX Vertex Pharmaceuticals Inc	422.00	108.68B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	681.58	74.90B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	640.52	38.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	246.27	31.76B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	111.93	26.83B	3.30B	-501.07M	1.03B	-2.1146

Crispr Therapeutics Ag Stock (CRSP) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-06	Reiterato	Needham	Buy
2024-08-02	Iniziato	Rodman & Renshaw	Buy
2024-06-28	Ripresa	Guggenheim	Neutral
2024-02-15	Iniziato	Wolfe Research	Peer Perform
2023-12-11	Downgrade	TD Cowen	Market Perform → Underperform
2023-10-17	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2023-09-27	Iniziato	Mizuho	Buy
2023-08-17	Aggiornamento	Citigroup	Neutral → Buy
2023-05-30	Iniziato	William Blair	Outperform
2023-04-13	Iniziato	Cantor Fitzgerald	Overweight
2023-03-21	Iniziato	Bernstein	Mkt Perform
2023-03-17	Iniziato	Bryan Garnier	Buy
2023-03-07	Iniziato	Robert W. Baird	Neutral
2022-10-11	Iniziato	Morgan Stanley	Underweight
2022-08-09	Downgrade	Barclays	Overweight → Equal Weight
2022-06-23	Downgrade	Evercore ISI	Outperform → In-line
2022-06-17	Iniziato	BMO Capital Markets	Outperform
2022-04-28	Iniziato	Credit Suisse	Neutral
2021-12-07	Iniziato	Cowen	Market Perform
2021-10-19	Iniziato	SVB Leerink	Outperform
2021-06-14	Aggiornamento	Citigroup	Sell → Neutral
2021-04-21	Aggiornamento	Jefferies	Hold → Buy
2021-03-04	Iniziato	JMP Securities	Mkt Outperform
2020-12-10	Reiterato	Chardan Capital Markets	Buy
2020-12-10	Downgrade	Jefferies	Buy → Hold
2020-12-10	Reiterato	Needham	Buy
2020-12-07	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-10-23	Iniziato	RBC Capital Mkts	Sector Perform
2020-10-05	Iniziato	BofA Securities	Buy
2020-07-28	Reiterato	Needham	Buy
2020-07-14	Iniziato	SunTrust	Buy
2020-06-15	Reiterato	Canaccord Genuity	Buy
2020-03-05	Iniziato	Stifel	Hold
2020-02-03	Downgrade	Evercore ISI	Outperform → In-line
2019-11-19	Aggiornamento	William Blair	Mkt Perform → Outperform
2019-11-12	Aggiornamento	Oppenheimer	Perform → Outperform
2019-08-01	Iniziato	Jefferies	Buy
2019-07-26	Iniziato	Canaccord Genuity	Buy
2019-06-10	Iniziato	ROTH Capital	Buy
2019-04-12	Iniziato	Evercore ISI	Outperform
2019-03-14	Iniziato	William Blair	Mkt Perform
2019-01-28	Downgrade	Goldman	Buy → Neutral
2019-01-22	Downgrade	Citigroup	Neutral → Sell

Mostra tutto

Crispr Therapeutics Ag Borsa (CRSP) Ultime notizie

Jan 19, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Short Interest Up 5.4% in December - MarketBeat

Jan 19, 2025

Gene Editing Market Overview and Leading Players: Horizon - openPR

Jan 19, 2025

Jan 18, 2025

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia - Benzinga

Jan 18, 2025

Jan 17, 2025

CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell? - MSN

Jan 17, 2025